- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Reimbursement Reform Successfully Reduced Preventable Conditions
Researchers at Stanford University found that when CMS stopped paying for 2 preventable, hospital-acquired conditions in particular, the incidence of the conditions dropped 35% in the Medicare population.
Efforts to reduce preventable, hospital-acquired conditions have been working. At the beginning of December, HHS released a report that found these adverse events had decreased by 17% over 3 years, and CMS recently announced that more than 700 hospitals would be penalized because of their poor performance with hospital-acquired conditions.
Researchers at Stanford University have found that when CMS stopped paying the additional cost of treating the preventable, hospital-acquired conditions pulmonary embolism and deep-vein thrombosis, the incidence of these conditions after hip or knee replacement surgery dropped 35% in the Medicare population.
“We have a win-win. We have patients who are avoiding adverse events while Medicare saves money,” lead author Risha Gidwani, DrPH, a consulting assistant professor of medicine at Stanford and a health economist at the Veterans Affairs Health Economics Resource Center in Menlo Park, said in a statement.
While they did find that the incidence of these 2 conditions increased among the younger, non-Medicare population, they did decrease among patients older than age 65 who had private insurers.
The authors examined records from 2007-2006 from a national database of hospital discharges and compared Medicare patients ages 65-69 years who received hip or knee replacements with non-Medicare patients ages 60-64 who also received these procedures.
Overall, the reimbursement reform worked, according to Gidwani, who said the results of the study are important for payers considering expanding value-based purchasing programs.
“It may seem obvious that Medicare should use payment incentives for providers to encourage better and more appropriate care for patients, but there is always a risk of unintended consequences when Medicare cuts payments for services,” Jay Bhattacharya, MD, PhD, professor of medicine and director of the Stanford Program on Medical Outcomes and co-author, said. “In this case, we have found evidence that Medicare’s refusal to pay for complications arising from hip and knee surgeries really did reduce the incidence of those complications.”
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
